Page last updated: 2024-12-05
propyl nitrate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
propyl nitrate: C3-H7-N-O3 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 12307 |
| CHEMBL ID | 188554 |
| SCHEMBL ID | 324772 |
| MeSH ID | M0379974 |
Synonyms (33)
| Synonym |
|---|
| propylester kyseliny dusicne |
| 983r6rcp6f , |
| nitrate de propyle normal |
| n-propyl nitrate [un1865] [flammable liquid] |
| unii-983r6rcp6f |
| propylester kyseliny dusicne [czech] |
| hsdb 7198 |
| monopropyl nitrate |
| nitrate de propyle normal [french] |
| einecs 210-985-0 |
| un1865 |
| brn 1701406 |
| nitric acid, propyl ester |
| propyl nitrate |
| inchi=1/c3h7no3/c1-2-3-7-4(5)6/h2-3h2,1h |
| n-propyl nitrate |
| bdbm50156306 |
| 1-nitrooxy-propane |
| CHEMBL188554 , |
| AKOS006274317 |
| 627-13-4 |
| nitric acid propyl ester |
| FT-0632646 |
| propyl nitrate [mi] |
| un-1865 |
| SCHEMBL324772 |
| DTXSID2060834 |
| n-c3h7ono2 |
| un 1865 |
| propylnitrat |
| Q18816316 |
| BS-29076 |
| n-propyl nitrate (stabilized) |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (6)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID248828 | Tested for inhibition of ferrous salt/ascorbate induced lipidic peroxidation of membrane lipid of rat hepatocytes at 1 mM; IA = inactive | 2004 | Bioorganic & medicinal chemistry letters, Dec-20, Volume: 14, Issue:24 | Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants. |
| AID264515 | Vasodilator activity assessed as ability to relax phenylephrine-induced contraction of Wistar rat aortic strips | 2006 | Journal of medicinal chemistry, May-18, Volume: 49, Issue:10 | NO-donor phenols: a new class of products endowed with antioxidant and vasodilator properties. |
| AID246502 | Vasodilating activity in rat aorta strip in absence of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) | 2004 | Bioorganic & medicinal chemistry letters, Dec-20, Volume: 14, Issue:24 | Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants. |
| AID264514 | Antioxidant activity assessed as inhibition of TBARS production in ferrous salt/ascorbate-induced lipid peroxidation in Wistar rat liver microsomal membrane at 1 mM | 2006 | Journal of medicinal chemistry, May-18, Volume: 49, Issue:10 | NO-donor phenols: a new class of products endowed with antioxidant and vasodilator properties. |
| AID264517 | Vasodilator activity assessed as ability to relax phenylephrine-induced contraction of Wistar rat aortic strips at 100 uM in presence of 1 uM ODQ | 2006 | Journal of medicinal chemistry, May-18, Volume: 49, Issue:10 | NO-donor phenols: a new class of products endowed with antioxidant and vasodilator properties. |
| AID246571 | Vasodilating activity in rat aorta strip in presence of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) at 100 uM | 2004 | Bioorganic & medicinal chemistry letters, Dec-20, Volume: 14, Issue:24 | Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 45.81
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (45.81) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||